Drug Type Recombinant polypeptide |
Synonyms CBT 005(C-BIOMEX), CBT005(C-BIOMEX) |
Target |
Mechanism NPRB inhibitors(Atrial natriuretic peptide receptor type B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Achondroplasia | Preclinical | KR | 16 May 2024 |